Author
UCB Pharma (United Kingdom)ORCID 0000-0003-4855-7329Unclaimed ORCID profile · follow to get notified of new preprints
3 papers
Recent·Most cited
Christos Maniatis, Zahra Ouaray, Chengkai Xiao…·Jacob M. Hurst
DoRIAT improves docking run interpretation by selecting models close to native structures, achieving top 10 rankings in 80% of cases using RMSD.
Emilia Wysocka, Matthew Page, James Snowden, T. Ian Simpson
This study compares rule-based and ODE models of the DARPP-32 signalling network, finding that rule-based models offer greater flexibility and detail in capturing molecular dynamics.
Wing Ki Wong, Sarah A. Robinson, Alexander Bujotzek…·Charlotte Mary Deane
Ab-Ligity identifies sequence-dissimilar antibodies that bind to the same epitope by analyzing antibody-antigen interfaces, outperforming existing tools in precision and speed.